المؤلفون: Annelli Sandbæk, Signe S. Rasmussen, Daniel R. Witte, Knut Borch-Johnsen, Jesper Eugen-Olsen, Troels Mygind Jensen, Steen B. Haugaard, T. Lauritzen, Alexandros Heraclides

المصدر: Heraclides, A, Jensen, T M, Rasmussen, S S, Eugen-Olsen, J, Haugaard, S B, Borch-Johnsen, K, Sandbaek, A, Lauritzen, T & Witte, D R 2013, ' The pro-inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is associated with incident type 2 diabetes among overweight but not obese individuals with impaired glucose regulation: effect modification by smoking and body weight status ', Diabetologia, vol. 56, no. 7, pp. 1542-1546 . https://doi.org/10.1007/s00125-013-2914-0
Heraclides, A, Jensen, T M, Rasmussen, S S, Eugen-Olsen, J, Haugaard, S B, Borch-Johnsen, K, Sandbæk, A, Lauritzen, T & Witte, D 2013, ' The pro-inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is associated with incident type 2 diabetes among overweight but not obese individuals with impaired glucose regulation : effect modification by smoking and body weight status ', Diabetologia, vol. 56, no. 7, pp. 1542-1546 . https://doi.org/10.1007/s00125-013-2914-0

مصطلحات موضوعية: Male, medicine.medical_specialty, Diabetes risk, Endocrinology, Diabetes and Metabolism, Type 2 diabetes, Overweight, Body Mass Index, Receptors, Urokinase Plasminogen Activator, Diabetes mellitus, Internal medicine, Internal Medicine, Medicine, Humans, Obesity, BMI Body mass index Impaired glucose regulation Incident type 2 diabetes Smoking Soluble urokinase plasminogen activator receptor Sub-clinical inflammation suPAR POPULATION CANCER UPAR, business.industry, Body Weight, Smoking, medicine.disease, Endocrinology, SuPAR, Diabetes Mellitus, Type 2, Biomarker (medicine), Biological Markers, Female, medicine.symptom, business, Body mass index, Biomarkers

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e40c5df97968129f9ce4aea67836de3
https://pubmed.ncbi.nlm.nih.gov/23613086

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.